Summary
Sanai Health Industry Group Company Limited, an investment holding company, develops, manufactures, markets, and sells pharmaceutical products in the People's Republic of China. It operates through three segments: Pharmaceutical Products, Finance Leasing, and Genetic Testing and Molecular Diagnostic Services. The company provides branded prescription and non-prescription drugs, as well as Chinese pharmaceutical products. It offers products primarily in the therapeutic areas of respiratory, cardiovascular, gastrointestinal nutrient, antibiotics, antiviral, antifungal drugs, and other diseases. The company also engages in the sale of pharmaceutical related software and provision of consultancy services; finance leasing; and provision of genetic testing and molecular diagnostic services. The company was formerly known as Wuyi International Pharmaceutical Company Limited and changed its name to Sanai Health Industry Group Company Limited in November 2017. Sanai Health Industry Group Company Limited was incorporated in 2006 and is based in Kwun Tong, Hong Kong.